{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:03:01Z","timestamp":1788850981843,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L0236687\/1"],"award-info":[{"award-number":["BB\/L0236687\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0283-7","type":"journal-article","created":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T21:19:35Z","timestamp":1467407975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro"],"prefix":"10.1186","volume":"15","author":[{"given":"Khalida Ann","family":"Lockman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varanand","family":"Htun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Treskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard J.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie M.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Le Bihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Plevris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,2]]},"reference":[{"key":"283_CR1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10:686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"283_CR2","doi-asserted-by":"crossref","unstructured":"Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124\u201331.","DOI":"10.1053\/j.gastro.2010.09.038"},{"key":"283_CR3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","volume":"10","author":"GC Farrell","year":"2013","unstructured":"Farrell GC, Wong VW, Chitturi S. NAFLD in Asia--as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307\u201318.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"283_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00125480-200201000-00005","volume":"9","author":"MJ Contos","year":"2002","unstructured":"Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol. 2002;9:37\u201351.","journal-title":"Adv Anat Pathol"},{"key":"283_CR5","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120:1183\u201392.","DOI":"10.1053\/gast.2001.23256"},{"key":"283_CR6","doi-asserted-by":"crossref","unstructured":"Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem. 2009;284:14809\u201318.","DOI":"10.1074\/jbc.M901488200"},{"key":"283_CR7","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.1074\/jbc.M701759200","volume":"282","author":"R Kohli","year":"2007","unstructured":"Kohli R, Pan X, Malladi P, Wainwright MS, Whitington PF. Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway. J Biol Chem. 2007;282:21327\u201336.","journal-title":"J Biol Chem"},{"key":"283_CR8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology. 2010;52:774\u201388.","journal-title":"Hepatology"},{"key":"283_CR9","doi-asserted-by":"crossref","first-page":"H2124","DOI":"10.1152\/ajpheart.2000.279.5.H2124","volume":"279","author":"GC Sparagna","year":"2000","unstructured":"Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol. 2000;279:H2124\u201332.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"283_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2013.10.009","volume":"63","author":"RA Egnatchik","year":"2014","unstructured":"Egnatchik RA, Leamy AK, Noguchi Y, Shiota M, Young JD. Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. Metabolism. 2014;63:283\u201395.","journal-title":"Metabolism"},{"key":"283_CR11","doi-asserted-by":"crossref","unstructured":"Younossi ZM, Baranova A, Ziegler K, Del Giacco L, Schlauch K, Born TL, et al. A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease. Hepatology. 2005;42:665\u201374.","DOI":"10.1002\/hep.20838"},{"key":"283_CR12","doi-asserted-by":"crossref","unstructured":"Bell LN, Theodorakis JL, Vuppalanchi R, Saxena R, Bemis KG, Wang M, et al. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology. 2010;51:111\u201320.","DOI":"10.1002\/hep.23271"},{"key":"283_CR13","doi-asserted-by":"crossref","unstructured":"Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, Plevris-Papaioannou N, et al. Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. Liver Int. 2012;32:1079\u201392.","DOI":"10.1111\/j.1478-3231.2012.02775.x"},{"key":"283_CR14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/rcm.4487","volume":"24","author":"T Bihan Le","year":"2010","unstructured":"Le Bihan T, Grima R, Martin S, Forster T, Le Bihan Y. Quantitative analysis of low-abundance peptides in HeLa cell cytoplasm by targeted liquid chromatography\/mass spectrometry and stable isotope dilution: emphasising the distinction between peptide detection and peptide identification. Rapid Commun Mass Spectrom. 2010;24:1093\u2013104.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"283_CR15","doi-asserted-by":"crossref","unstructured":"Yeung EN, Treskes P, Martin SF, Manning JR, Dunbar DR, Rogers SM, et al. Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events? Lipids Health Dis. 2015;14:86.","DOI":"10.1186\/s12944-015-0069-3"},{"key":"283_CR16","doi-asserted-by":"crossref","first-page":"W96","DOI":"10.1093\/nar\/gkq418","volume":"38","author":"V Kaimal","year":"2010","unstructured":"Kaimal V, Bardes EE, Tabar SC, Jegga AG, Aronow BJ. ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems. Nucleic Acids Res. 2010;38:W96\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"283_CR17","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1093\/bioinformatics\/bti610","volume":"21","author":"A Conesa","year":"2005","unstructured":"Conesa A, Gotz S, Garcia-Gomez JM, Terol J, Talon M, Robles M. Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics. 2005;21:3674\u20136.","journal-title":"Bioinformatics"},{"key":"283_CR18","doi-asserted-by":"crossref","unstructured":"Guzman C, Benet M, Pisonero-Vaquero S, Moya M, Garcia-Mediavilla MV, Martinez-Chantar ML, et al. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARalpha; and repressed by C\/EBPalpha: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim Biophys Acta. 2013;1831:803\u201318.","DOI":"10.1016\/j.bbalip.2012.12.014"},{"key":"283_CR19","doi-asserted-by":"crossref","unstructured":"Charlton M, Viker K, Krishnan A, Sanderson S, Veldt B, Kaalsbeek AJ, et al. Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology. 2009;49:1375\u201384.","DOI":"10.1002\/hep.22927"},{"key":"283_CR20","doi-asserted-by":"crossref","unstructured":"Motomura W, Inoue M, Ohtake T, Takahashi N, Nagamine M, Tanno S, et al. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. Biochem Biophys Res Commun. 2006;340:1111\u20138.","DOI":"10.1016\/j.bbrc.2005.12.121"},{"key":"283_CR21","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1194\/jlr.M700359-JLR200","volume":"48","author":"LL Listenberger","year":"2007","unstructured":"Listenberger LL, Ostermeyer-Fay AG, Goldberg EB, Brown WJ, Brown DA. Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover. J Lipid Res. 2007;48:2751\u201361.","journal-title":"J Lipid Res"},{"key":"283_CR22","doi-asserted-by":"crossref","unstructured":"McManaman JL, Bales ES, Orlicky DJ, Jackman M, MacLean PS, Cain S, et al. Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease. J Lipid Res. 2013;54:1346\u201359.","DOI":"10.1194\/jlr.M035063"},{"key":"283_CR23","doi-asserted-by":"crossref","unstructured":"Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15:665\u201374.","DOI":"10.1016\/j.cmet.2012.04.004"},{"key":"283_CR24","doi-asserted-by":"crossref","first-page":"e60895","DOI":"10.1371\/journal.pone.0060895","volume":"8","author":"C Boudiaf-Benmammar","year":"2013","unstructured":"Boudiaf-Benmammar C, Cresteil T, Melki R. The cytosolic chaperonin CCT\/TRiC and cancer cell proliferation. PLoS One. 2013;8:e60895.","journal-title":"PLoS One"},{"key":"283_CR25","doi-asserted-by":"crossref","first-page":"e0131269","DOI":"10.1371\/journal.pone.0131269","volume":"10","author":"AM Stoianov","year":"2015","unstructured":"Stoianov AM, Robson DL, Hetherington AM, Sawyez CG, Borradaile NM. Elongation factor 1A-1 Is a mediator of hepatocyte lipotoxicity partly through its canonical function in protein synthesis. PLoS One. 2015;10:e0131269.","journal-title":"PLoS One"},{"key":"283_CR26","doi-asserted-by":"crossref","unstructured":"Borradaile NM, Buhman KK, Listenberger LL, Magee CJ, Morimoto ET, Ory DS, et al. A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death. Mol Biol Cell. 2006;17:770\u20138.","DOI":"10.1091\/mbc.E05-08-0742"},{"key":"283_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.tibs.2009.03.006","volume":"34","author":"M Campanella","year":"2009","unstructured":"Campanella M, Parker N, Tan CH, Hall AM, Duchen MR. IF(1): setting the pace of the F(1)F(o)-ATP synthase. Trends Biochem Sci. 2009;34:343\u201350.","journal-title":"Trends Biochem Sci"},{"key":"283_CR28","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1074\/jbc.M006655200","volume":"276","author":"ME Burczynski","year":"2001","unstructured":"Burczynski ME, Sridhar GR, Palackal NT, Penning TM. The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha, beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J Biol Chem. 2001;276:2890\u20137.","journal-title":"J Biol Chem"},{"key":"283_CR29","doi-asserted-by":"crossref","unstructured":"Jung KA, Choi BH, Nam CW, Song M, Kim ST, Lee JY, et al. Identification of aldo-keto reductases as NRF2-target marker genes in human cells. Toxicol Lett. 2013;218:39\u201349.","DOI":"10.1016\/j.toxlet.2012.12.026"},{"key":"283_CR30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.molcel.2005.02.019","volume":"17","author":"M Bustin","year":"2005","unstructured":"Bustin M, Catez F, Lim JH. The dynamics of histone H1 function in chromatin. Mol Cell. 2005;17:617\u201320.","journal-title":"Mol Cell"},{"key":"283_CR31","doi-asserted-by":"crossref","unstructured":"Rochman M, Taher L, Kurahashi T, Cherukuri S, Uversky VN, Landsman D, et al. Effects of HMGN variants on the cellular transcription profile. Nucleic Acids Res. 2011;39:4076\u201387.","DOI":"10.1093\/nar\/gkq1343"},{"key":"283_CR32","doi-asserted-by":"crossref","unstructured":"Celona B, Weiner A, Di Felice F, Mancuso FM, Cesarini E, Rossi RL, et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 2011;9:e1001086.","DOI":"10.1371\/journal.pbio.1001086"},{"key":"283_CR33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3344","volume":"12","author":"G Sulli","year":"2012","unstructured":"Sulli G, Di Micco R, d\u2019Adda di Fagagna F. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer. 2012;12:709\u201320.","journal-title":"Nat Rev Cancer"},{"key":"283_CR34","first-page":"1580","volume":"52","author":"MC Elia","year":"1992","unstructured":"Elia MC, Bradley MO. Influence of chromatin structure on the induction of DNA double strand breaks by ionizing radiation. Cancer Res. 1992;52:1580\u20136.","journal-title":"Cancer Res"},{"key":"283_CR35","doi-asserted-by":"crossref","unstructured":"Aravinthan A, Scarpini C, Tachtatzis P, Verma S, Penrhyn-Lowe S, Harvey R, et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J Hepatol. 2013;58:549\u201356.","DOI":"10.1016\/j.jhep.2012.10.031"},{"key":"283_CR36","doi-asserted-by":"crossref","unstructured":"Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB, et al. The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. Cell Cycle. 2012;11:1918\u201328.","DOI":"10.4161\/cc.20259"},{"key":"283_CR37","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","volume":"17","author":"MS Cooke","year":"2003","unstructured":"Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;17:1195\u2013214.","journal-title":"FASEB J"},{"key":"283_CR38","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820\u201332.","journal-title":"Hepatology"},{"key":"283_CR39","doi-asserted-by":"crossref","unstructured":"Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology. 2008;135:2128\u201340. 2140 e2121-2128.","DOI":"10.1053\/j.gastro.2008.07.027"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0283-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T11:37:43Z","timestamp":1568115463000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0283-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,2]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0283-7","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,2]]},"article-number":"114"}}